High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma

Laboratory Investigation

Volumn 88, Issue 5, 2008, Pages 464-473

  Bernheim, Alain ^a   Toujani, Saloua ^a   Saulnier, Patrick ^a   Robert, Thomas ^a   Casiraghi, Odile ^a   Validire, Pierre ^b   Temam, Stéphane ^a   Menard, Philippe ^c,d   Dessen, Philippe ^a   Fouret, Pierre ^a,d  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Adenoid cystic carcinoma; Array comparative genomic hybridization; C kit; mdm2 head and neck; microRNA

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; GELATINASE A; MICRORNA; PROTEIN P53;

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME NUMBER; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; ENZYME REGULATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE NUMBER; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; BRONCHIAL NEOPLASMS; CARCINOMA, ADENOID CYSTIC; CHROMOSOME ABERRATIONS; FEMALE; GENE DELETION; GENE DOSAGE; GENES, TUMOR SUPPRESSOR; GENOME, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PROTO-ONCOGENE PROTEINS C-MDM2; SALIVARY GLAND NEOPLASMS;

EID: 42549101376     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.18     Document Type: Article

References (25)

1. El-Naggar A, Huvos A. Adenoid cystic carcinoma. In: Barnes L, Eveson J, Reichart P, Sidransky D (eds). Pathology and Genetics of Head and Neck Tumours (World Health Organization Classification of Tumours), 1st edn. IARC Press: Lyon, France, 2005, pp 221-222.
2. Dodd R, Slevin N. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 2006;42:759-769.
3. Faivre S, Raymond E, Casiraghi O, et al. Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands. J Clin Oncol 2005;23:6271-6273.
4. Pfeffer M, Talmi Y, Catane R, et al. A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands. Oral Oncol 2006;43:33-36.
5. Holst V, Marshall C, Moskaluk C, et al. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol 1999;12:956-960.
6. Albertson D, Collins C, McCormick F, et al. Chromosome aberrations in solid tumors. Nat Genet 2003;34:369-376.
7. El-Rifai W, Rutherford S, Knuutila S, et al. Novel DNA copy number losses in chromosome 12q12-q13 in adenoid cystic carcinoma. Neoplasia 2001;3:173-178.
8. Freier K, Flechtenmacher C, Walch A, et al. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet 2005;159:89-95.
9. Rutherford S, Yu Y, Rumpel C, et al. Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma. Cancer Lett 2006;236:309-317.
10. Rutherford S, Hampton G, Frierson H, et al. Mapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinoma. Lab Invest 2005;85:1076-1085.
11. Yu Y, Baras A, Shirasuna K, et al. Concurrent loss of heterozygosity and copy number analysis in adenoid cystic carcinoma by SNP genotyping arrays. Lab Invest 2007;87:430-439.
12. Vékony H, Ylstra B, Wilting S, et al. DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma. Clin Cancer Res 2007;13:3133-3139.
13. Huret JL, Dessen P, Bernheim A. Atlas of genetics and cytogenetics in oncology and haematology. Nucleic Acids Res 2003;31:272-274.
14. Ylstra B, van den Ijssel P, Carvalho B, et al. BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH). Nucleic Acids Res 2006;34:445-450.
15. Wicker N, Carles A, Mills I, et al. A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH. BMC Genomics 2007;8:84.
16. Pinkel D, Albertson D. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005;37:S11-S17.
17. Tan DS, Lambros MB, Natrajan R, et al. Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research. Lab Invest 2007;87:737-754.
18. Maruya S, Kurotaki H, Shimoyama N, et al. Expression of p16 protein and hypermethylation status of its promoter gene in adenoid cystic carcinoma of the head and neck. ORL J Otorhinolaryngol Relat Spec 2003;65:26-32.
19. Li J, El-Naggar A, Mao L. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma. Cancer 2005;104:771-776.
20. Pammer J, Weninger W, Mildner M, et al. Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pathol 1998;186:186-191.
21. Frierson H, El-Naggar A, Welsh J, et al. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 2002;161:1315-1323.
22. Maul R, Chang D. EPLIN, epithelial protein lost in neoplasm. Oncogene 1999;18:7838-7841.
23. Calin G, Sevignani C, Dumitru C, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;101:2999-3004.
24. Lujambio A, Ropero S, Ballestar E, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007;67:1424-1429.
25. Yekta S, Shih I, Bartel D. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004;304:594-596.